New research suggests that giving people with existing mental health conditions formal 'green prescriptions', may undermine some of the benefits.

Neuroscientists at UCL have used laser beams to "switch on" neurons in mice, providing new insight into the hidden workings of memory.

National Institutes of Health researchers have discovered a gene in mice that controls the craving for fatty and sugary foods and the desire to exercise.

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to what has become the COVID-19 pandemic.

To learn more about the PANDIS model, its aims, and how it can be used to help diagnose and treat patients suffering from a range of conditions spanning from cancers to “mystery chronic diseases”, Technology Networks spoke with PANDIS’s founders, Professor Gilles Guillemin and Catherine Stace.

The first widespread reports that SARS-CoV-2 might be affecting our nervous system were quite innocuous. But over the following months, reports of far more severe neurological side effects emerged. In this article, we take a look at the neurological symptoms of COVID-19.

Clinical trials are a significant milestone in the development of innovative drugs and therapies for people diagnosed with different medical conditions including multiple sclerosis (MS). In this article, we examine how technology can make it easier for people to find and enroll on clinical trials.

As microscopes have improved, so too has their resolution and their ability to image cellular substructure, even down to the single-molecule level. Researchers can now investigate the carefully orchestrated trafficking and interaction of organelles, cargo, and biomolecules that sustain cellular life.

A profile piece exploring the life and career of the molecular biologist Professor Oded Rechavi.